Natural treatment for stroke recovery. Clinically safe.
Doubles chances of reaching independence

NeuroAiD survey report

At Moleac we are well aware that medicine is for the people, and people is what we care for. NeuroAiD has been and continues to be tested clinically for its safety and efficacy on a variety of conditions. The results continue to be published in peer-reviewed medical journals.

We did not want to stop there, we want to hear more from our own customers about their experience, that is why we continuously survey our customers and monitor their progress. We thought such a survey would help answer the frequent question “what are my chances and risk with NeuroAiD?” Here below are the result of a survey conducted in 2010 on patients who purchased NeuroAiD for at least 1 month (inclusive) of treatment between January 1st 2009 and February 28th, 2010. Customers were emailed an on-line questionnaire in three different languages (English, French and Spanish). We received 144 answers which are the basis for the chart below. We are currently conducting a survey of all customers who purchased NeuroAiD in 2011 and results will be published by the second quarter of 2012.

Here are the results of our last customer survey on patients who purchased NeuroAiD and we would love to share these insights with you.

 

Tolerance to NeuroAiD

NeuroAiD is a natural product and has no known drug interactions. Several studies have proven the safety profile of NeuroAiD. Our customer report support the findings in these clinical studies: 90% of patients report no side effect when taking NeuroAiD.

Side effects reported are mild and usually in the form of digestive discomfort (due to the high herbal concentration), allergy or headache.

 

Efficacy of NeuroAiD

There are many factors that can affect the outcome of NeuroAiD treatment. These factors include age of the patient, the diverse nature of strokes and the different degree of rehabilitation intensity and effort to which patients are exposed. Therefore the observed improvement when taking NeuroAiD varies from patient to patient. Nevertheless, we are happy to see that 70% of patients experience improvement when taking NeuroAiD.

The reported efficacy tends to be better in patients who suffered a stroke more recently. Furthermore, 68% of the respondents experienced a better recovery in motor functions and 52% experienced a noticeable improvement in aphasia.

 

The take home message

We are glad to see that the reported tolerability and efficacy are in consonance with published clinical studies. The reasons why most patients respond positively to the treatment is because NeuroAiD have shown to trigger multiple mechanisms enhancing the brain’s own capability to recover after an injury, a process called neuroplasticity (you can learn more about it here). However we would like to stress that NeuroAiD is not a miracle cure, in any given treatment there is a percentage of patients that does not respond well or does not respond at all. The reasons for this vary greatly from patient to patient. Some of the factors affecting the outcome of the treatment may be the own and unique genetic background of the patient, the age of the patient, how long after stroke NeuroAiD treatment started, the severity and type of stroke, other concomitant diseases, rehabilitation routine, etc. We are happy to see that about 70% of customers have reported improvement but we also empathize that 30% have not benefited from the NeuroAiD treatment.

NeuroAiD helps stroke recovery by providing a good environment for the growth of new neurons in the brain and it is especially effective when combined with rehabilitation exercises. Clinical studies have indicated that NeuroAiD acts as a booster in stroke recovery.

Posted on January 4, 2012

Neuroplasticity and Stroke

To what extent are our brains shaped by our actions, our perceptions or even by our imagination? Is there a way for adults to re-wire their brain? These are just 2 of the questions asked and addressed by Dr. Norman Doidge’s 2008 bestseller, “The Brain Changes Itself.

Dr. Doidge is a research psychiatrist and psychoanalyst, who wrote about one of the most exciting discoveries of the 21st Century – neuroplasticity.

Continue reading

Posted on March 1, 2011

Clinical Experiences with NeuroAiD

NeuroAiD originates from Traditional Chinese Medicine. It has been used in clinical practice since over 10 years. A certain number of clinical trials and case reports have been published on famous scientific journals. NeuroAiD’s safety and efficacy are being kept investigated through these persuasive records.

The initial clinical trials in China on 605 patients have showed good tolerability and superiority over another TCM medicine approved for stroke, in improving neurological recovery by 2.4 times. This has given an idea to start another clinical trial at bigger scale, international and multi-centre, double-blind, placebo-controlled, and randomized Phase II Pilot study to investigate NeuroAiD’s efficacy in acute phase of stroke recovery Chimes. The study is still on-going with more than 600 randomized patients. Continue reading

Posted on November 19, 2010